Canyon Capital Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-578,832
Closed -$47.1M 29
2023
Q2
$47.1M Sell
578,832
-818,950
-59% -$58.3M 4.65% 7
2023
Q1
$83.1M Sell
1,397,782
-468,000
-25% -$26M 12.27% 3
2022
Q4
$91M Sell
1,865,782
-18,100
-1% -$837K 10.09% 3
2022
Q3
$97.2M Hold
1,883,882
9.54% 3
2022
Q2
$99M Buy
1,883,882
+299,913
+19% +$20.9M 7.85% 5
2022
Q1
$136M Sell
1,583,969
-94,790
-6% -$7.79M 5.04% 4
2021
Q4
$137M Buy
1,678,759
+190,059
+13% +$13.9M 4.67% 3
2021
Q3
$98.9M Buy
1,488,700
+450,100
+43% +$31.9M 3.48% 5
2021
Q2
$69.6M Buy
1,038,600
+168,600
+19% +$10.5M 2.58% 12
2021
Q1
$45.2M Buy
+870,000
New +$44M 1.79% 19

Other funds holding THC

Canyon Capital Advisors's THC Position: Q3 2023 in Review

Canyon Capital Advisors sold out of Tenet Healthcare (THC) in Q3 2023, closing a stake of 578,832 shares — an estimated $47.1M sold.

Canyon Capital Advisors first reported a position in THC in Q1 2021 and held it in 10 quarters. The position peaked at $137M in Q4 2021. 407 funds tracked by Wall St. Rank hold THC as of Q3 2023.

  • Canyon Capital Advisors reported no remaining Tenet Healthcare position as of Q3 2023 after selling out during the quarter.
  • Canyon Capital Advisors sold 578,832 Tenet Healthcare shares in Q3 2023, an estimated $47.1M.
  • Canyon Capital Advisors first reported a position in Tenet Healthcare in Q1 2021 and held it in 10 quarters.
  • Canyon Capital Advisors's Tenet Healthcare position peaked at $137M in Q4 2021.
  • 407 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2023.

Based on Canyon Capital Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.